{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T20:34:49Z","timestamp":1723062889015},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1111\/j.1574-695x.2006.00115.x","type":"journal-article","created":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T14:25:36Z","timestamp":1149863136000},"page":"26-33","source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular risk factors in chronic Chagas' disease are associated with a different profile of putative heart-pathogenic antibodies"],"prefix":"10.1093","volume":"48","author":[{"given":"Cristina","family":"Diez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Gea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00c3\u00a1n","family":"Marcipar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella Maris","family":"Pezzotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Beloscar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Pellizzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Marcipar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Bottasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB1","doi-asserted-by":"crossref","unstructured":"Andrade Z (1999) Immunopathology of Chagas' disease. Mem Inst Oswaldo Cruz 94: 71\u00e2\u0080\u009380.","DOI":"10.1590\/S0074-02761999000700007"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB2","unstructured":"Avila JL , Rojas M & Carrasco H (1993) Elevated levels of antibodies against sulphatide are present in all chronic chagasic and non-chagasic dilatatory cardiomyopathy sera. Clin Exp Immunol 92: 460\u00e2\u0080\u0093465."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB3","unstructured":"Aznar C , Lopez-Bergami P , Brandariz S , et al. (1995) Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection. FEMS Immunol Med Microbiol 12: 231\u00e2\u0080\u0093238."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB4","unstructured":"Berra H , Carnevali F , Revelli S , Moreno H , Pezzotto SM , Morini JC & Bottasso OA (1998) Electrocardiographic alterations in chronically Trypanosoma cruzi-infected persons exposed to cardiovascular risk factors. Arch Med Res 29: 241\u00e2\u0080\u0093246."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB5","doi-asserted-by":"crossref","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248\u00e2\u0080\u0093254.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB6","unstructured":"Brener Z & Gazzinelli RT (1997) Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114: 103\u00e2\u0080\u0093110."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB7","doi-asserted-by":"crossref","unstructured":"Cruz-Robles D , Reyes PA , Monte\u00c3\u00b3n-Padilla VM , Ortiz-Mu\u00c3\u00b1iz AR & Vargas-Alarc\u00c3\u00b3n G (2004) MHC class I and class II genes in Mexican patients with Chagas disease. Hum Immunol 65: 60\u00e2\u0080\u009365.","DOI":"10.1016\/j.humimm.2003.10.008"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB8","unstructured":"D\u00c3\u00a1vila H , Beloscar JS , Bottasso OA & Morini JC (1987) Alteraciones electrocardiogr\u00c3\u00a1ficas en individuos infectados con Tripanosoma cruzi con distintos tiempos de residencia en \u00c3\u00a1reas de alta endemicidad. Medicina (Buenos Aires) 47: 154\u00e2\u0080\u0093158."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB9","unstructured":"De Lederkremer R , Zingales B , Confalonieri A , Couto A , Martin N & Colli W (1985) In vivo incorporation of palmitic acid and galactose in glycolipids of Trypanosoma cruzi epimastigotes. Biochem Int 10: 78\u00e2\u0080\u009388."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB10","doi-asserted-by":"crossref","unstructured":"Duschak VG , Riarte A , Segura EL & Laucella SA (2001) Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease. Immunol Lett 78: 135\u00e2\u0080\u0093142.","DOI":"10.1016\/S0165-2478(01)00255-3"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB11","unstructured":"Feldman S , Garc\u00c3\u00ada G , Svetaz MJ , Avila JL , Revelli S , Bottasso OA & Marcipar A (1999) Evidence that antisulphatide autoantibodies from experimentally Trypanosoma cruzi-infected rats bind to homologous neural tissue. Parasitol Res 85: 446\u00e2\u0080\u0093451."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB13","doi-asserted-by":"crossref","unstructured":"Giordanengo L , Fretes R , Diaz H , Cano R , Bacile A , Vottero-Cima E & Gea S (2000a) Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice. Muscle Nerve 23: 1407\u00e2\u0080\u00931413.","DOI":"10.1002\/1097-4598(200009)23:9<1407::AID-MUS12>3.3.CO;2-V"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB12","doi-asserted-by":"crossref","unstructured":"Giordanengo L , Maldonado C , Rivarola HW , Iosa D , Girones N , Fresno M & Gea S (2000b) Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur J Immunol 30: 3181\u00e2\u0080\u00933189.","DOI":"10.1002\/1521-4141(200011)30:11<3181::AID-IMMU3181>3.0.CO;2-A"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB14","doi-asserted-by":"crossref","unstructured":"Girones N & Fresno M (2003) Etiology of Chagas disease myocarditis:autoimmunity, parasite persistence, or both? Trends Parasitol 19: 19\u00e2\u0080\u009322.","DOI":"10.1016\/S1471-4922(02)00006-5"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB15","unstructured":"Guidelines Subcommittee (1999) World Health Organization \u00e2\u0080\u0093 International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens 17: 151\u00e2\u0080\u0093183."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB16","doi-asserted-by":"crossref","unstructured":"Hartz AJ , Anderson AJ , Brooks HL , Manley JC , Parent GT & Barboriak J (1984) The association of smoking with cardiomyopathy. N Engl J Med 311: 1201\u00e2\u0080\u00931206.","DOI":"10.1056\/NEJM198411083111901"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB17","unstructured":"Higuchi ML , De Morais F , Pereira-Barreto AC , Lopes EA , Stolf N , Bellotti G & Pileggi F (1987) The role of active myocarditis in the development of heart failure in chronic Chagas disease:a study based on endomyocardial biopsies. Clin Cardiol 10: 665\u00e2\u0080\u0093670."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB18","doi-asserted-by":"crossref","unstructured":"Kalil J & Cunha-Neto E (1996) Autoimmunity in Chagas disease cardiomyopathy:fulfilling the criteria at last? Parasitol Today 12: 396\u00e2\u0080\u0093399.","DOI":"10.1016\/0169-4758(96)10058-2"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB19","unstructured":"Kirchhoff LV (1993) American trypanosomiasis (Chagas' disease). A tropical disease now in the United States. N Engl J Med 329: 639\u00e2\u0080\u0093644."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB20","doi-asserted-by":"crossref","unstructured":"Kohriyama T , Ariga T & Yu RK (1988) Preparation and characterization of antibodies against sulfated glucuronic acid-containing glycosphingolipid. J Neurochem 51: 869\u00e2\u0080\u0093877.","DOI":"10.1111\/j.1471-4159.1988.tb01823.x"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB21","doi-asserted-by":"crossref","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680\u00e2\u0080\u0093685.","DOI":"10.1038\/227680a0"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB22","unstructured":"Leon JS & Engman DM (2001) Autoimmunity in Chagas heart disease. Int J Parasitol 31: 555\u00e2\u0080\u0093561."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB23","doi-asserted-by":"crossref","unstructured":"Levitus G , Hontebeyre-Joskowicz M , Van Regenmortel M & Levin MJ (1991) Humoral autoimmune response to ribosomal P proteins in chronic Chagas' heart disease. Clin Exp Immunol 85: 413\u00e2\u0080\u0093417.","DOI":"10.1111\/j.1365-2249.1991.tb05741.x"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB24","unstructured":"Lopez Bergami P , Scaglione J & Levin MJ (2001) Antibodies against the carboxylterminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J 15: 2602\u00e2\u0080\u00932612."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB25","doi-asserted-by":"crossref","unstructured":"Marcipar I , Olivares ML , Robles L , Dekanty A , Marcipar A & Silber A (2004) The diagnostic performance of recombinant Trypanosoma cruzi ribosomal P2\u00ce\u00b2 protein is influenced by its expression system. Protein Expres Purif 34: 1\u00e2\u0080\u00937.","DOI":"10.1016\/j.pep.2003.11.022"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB26","doi-asserted-by":"crossref","unstructured":"Martinez J , Campetella O , Frasch ACC & Cazzulo JJ (1991) The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections. Infect Immun 59: 4275\u00e2\u0080\u00934277.","DOI":"10.1128\/IAI.59.11.4275-4277.1991"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB27","doi-asserted-by":"crossref","unstructured":"Masuda MO , Levin M , De Oliveira SF , Dos Santos Costa PC , Bergami PL , Dos Santos Almeida NA , Pedrosa RC , Ferrari I , Hoebeke J & Campos de Carvalho AC (1998) Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J 12: 1551\u00e2\u0080\u00931558.","DOI":"10.1096\/fasebj.12.14.1551"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB28","unstructured":"Montamat E , D'oro G , Gallerano R , Sosa R & Blanco A (1996) Characterization of Trypanosoma cruzi population by zymodemes:correlation with clinical picture. Am J Trop Med Hyg 55: 625\u00e2\u0080\u0093628."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB29","doi-asserted-by":"crossref","unstructured":"Morrot A , Strickland DK , Higuchi ML , Reis M , Pedrosa R & Scharfstein J (1997) Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes. Int Immunol 9: 825\u00e2\u0080\u0093834.","DOI":"10.1093\/intimm\/9.6.825"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB30","doi-asserted-by":"crossref","unstructured":"Novo S , Barbagallo M , Abrignani MG , Nardi E , Di Maria GU , Longo B , Mistretta A & Strano A (1997) Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ischemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease. Am J Hypertens 10: 843\u00e2\u0080\u0093851.","DOI":"10.1016\/S0895-7061(97)00127-1"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB31","doi-asserted-by":"crossref","unstructured":"Petry K , Nudelman E , Eisen H & Hakomori SI (1988) Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol Biochem Parasitol 30: 113\u00e2\u0080\u0093121.","DOI":"10.1016\/0166-6851(88)90104-1"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB32","unstructured":"Piano MR & Schwertz DW (1994) Alcoholic heart disease: a review. Heart Lung 23: 3\u00e2\u0080\u009317."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB33","doi-asserted-by":"crossref","unstructured":"Pontes-De-Carvalho L , Santana CC , Soares MB , Oliveira GG , Cunha-Neto E & Ribeiro-Dos-Santos R (2002) Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmunity 18: 131\u00e2\u0080\u0093138.","DOI":"10.1006\/jaut.2001.0574"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB34","unstructured":"Reis MM , Higuchi ML , Benvenuti LA , Aiello VD , Gutierrez PS , Bellotti G & Pileggi F (1997) An in situ quantitative immunohistochemical study of cytokines and IL-2R+in chronic human chagasic myocarditis:correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 83: 165\u00e2\u0080\u0093172."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB35","unstructured":"Risso MG , Garbarino GB , Mocetti E , Campetella O , Gonzalez Cappa SM , Buscaglia CA & Leguizamon MS (2004) Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J Infect Dis 189: 2250\u00e2\u0080\u00932259."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB36","unstructured":"Roberts DD (1991) Sulfatide-binding proteins. Chem Phys Lipids 42: 173\u00e2\u0080\u0093183."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB37","unstructured":"Saida K , Saida K , Brown MJ & Silberberg DH (1979) In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum. A morphological study. Am J Pathol 95: 99\u00e2\u0080\u0093116."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB38","unstructured":"Sharfstein J , Schechter M , Senna M , Peralta JM , Mendonca-Previato L & Miles MA (1986) Trypanosoma cruzi:characterization and isolation of a 57\/51,000 m.w. surface glycoprotein (GP57\/51) expressed by epimastigotes and bloodstream trypomastigotes. J Immunol 137: 1336\u00e2\u0080\u00931341."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB39","first-page":"247","volume-title":"Enfermedad de Chagas","author":"Storino","year":"1994"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB40","doi-asserted-by":"crossref","unstructured":"Szarfman A , Terranova VP , Rennard SI , Foidart JM , Fatima Lima M , Scheinman JI & Martin GR (1982) Antibodies to laminin in Chagas' disease. J Exp Med 155: 1161\u00e2\u0080\u00931171.","DOI":"10.1084\/jem.155.4.1161"},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB41","unstructured":"Towbin H , Rosenfelder G , Wieslander J , Avila JL , Rojas M , Szarfman A , Esser K , Nowack H & Timpl R (1987) Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl (alpha 1\u00e2\u0080\u00933) galactose epitopes. J Exp Med 166: 419\u00e2\u0080\u0093432."},{"key":"10.1111\/j.1574-695X.2006.00115.x-BIB42","first-page":"47","volume-title":"Cardiomiopat\u00c3\u00adas. Serie de Informes T\u00c3\u00a9cnicos","volume":"697","author":"World Health Organization","year":"1984"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/48\/1\/26\/19169484\/48-1-26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T11:18:07Z","timestamp":1586949487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2006.00115.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2006.00115.x","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}